| Dr Ravi Chandra Anjaneyalu Madineni, MD | |
|
830 Old Lancaster Rd, Suite 209, Bryn Mawr, PA 19010-3118 | |
| (610) 525-1061 | |
| (610) 525-3509 |
| Full Name | Dr Ravi Chandra Anjaneyalu Madineni |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 24 Years |
| Location | 830 Old Lancaster Rd, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649508631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD459497 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Thomas Jefferson University Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Main Line Healthcare | 1951215201 | 894 |
News Archive
Individuals with more education suffer less from asthma. Researchers writing in BioMed Central's open access journal Respiratory Research have found that having less than 12 years of formal schooling is associated with worse asthma symptoms.
Public health challenges such as poor diet, smoking and binge drinking are just a few lifestyle issues that could be addressed with some ‘design thinking' according to Design Council and the Local Government Association.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 5 days ago
| Entity Name | Jefferson University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326093675 PECOS PAC ID: 7911819180 Enrollment ID: O20040225000232 |
News Archive
Individuals with more education suffer less from asthma. Researchers writing in BioMed Central's open access journal Respiratory Research have found that having less than 12 years of formal schooling is associated with worse asthma symptoms.
Public health challenges such as poor diet, smoking and binge drinking are just a few lifestyle issues that could be addressed with some ‘design thinking' according to Design Council and the Local Government Association.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 5 days ago
| Entity Name | Main Line Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922077643 PECOS PAC ID: 1951215201 Enrollment ID: O20040308000373 |
News Archive
Individuals with more education suffer less from asthma. Researchers writing in BioMed Central's open access journal Respiratory Research have found that having less than 12 years of formal schooling is associated with worse asthma symptoms.
Public health challenges such as poor diet, smoking and binge drinking are just a few lifestyle issues that could be addressed with some ‘design thinking' according to Design Council and the Local Government Association.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ravi Chandra Anjaneyalu Madineni, MD 830 Old Lancaster Rd, Suite 209, Bryn Mawr, PA 19010-3118 Ph: (610) 525-1061 | Dr Ravi Chandra Anjaneyalu Madineni, MD 830 Old Lancaster Rd, Suite 209, Bryn Mawr, PA 19010-3118 Ph: (610) 525-1061 |
News Archive
Individuals with more education suffer less from asthma. Researchers writing in BioMed Central's open access journal Respiratory Research have found that having less than 12 years of formal schooling is associated with worse asthma symptoms.
Public health challenges such as poor diet, smoking and binge drinking are just a few lifestyle issues that could be addressed with some ‘design thinking' according to Design Council and the Local Government Association.
Immunomedics, Inc., a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today reported that consolidation treatment with fractionated yttrium-90 (Y-90) labeled epratuzumab, after induction therapy with rituximab and CHOP (R-CHOP) chemotherapy, improved remission status of adult patients with diffuse large B-cell lymphoma (DLBCL), a form of aggressive lymphoma.
Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced its financial results for the fourth quarter and year ended December 31, 2009.
› Verified 5 days ago
Dr. James A Kenning, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3855 West Chester Pike, Suite 245 Bryn Mawr Hosp Health Center, Bryn Mawr, PA 19073 Phone: 610-325-3880 Fax: 610-325-3887 |